Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy® (Tegomil Fumarate) in GermanyAt Tiefenbacher Group, we are deeply committed to developing and delivering high-quality, value-added pharmaceuticals that improve the lives of patients worldwide. In collaboration with our trusted partner Neuraxpharm we are proud to announce the successful launch of Riulvy ® (Tegomil Fumarate) 174 mg […]
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Google Maps. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information